Jennifer S. Martinez

Jennifer S. Martinez

Auto-generated profile, based on publicly available information

Jennifer S. Martinez

Department of Applied Physics and Materials Science and Center for Materials Interfaces in Research and Applications (¡MIRA!) Northern Arizona University 1900 S Knoles Dr Flagstaff AZ 86011 USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2010 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
JSJaswinder Sharma
Jaswinder Sharma
HYHsin-Chih Yeh
Hsin-Chih Yeh
HYHyojong Yoo
Hyojong Yoo
JWJames H. Werner
James H. Werner
JMJennifer S. Martinez
Jennifer S. Martinez
We report the synthesis and photophysical properties of silver-nanoclusters templated on DNA, with fluorescence excitation and emission at distinct wavelengths that are tuned to common laser excitation wavelengths.

10 July 2012 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
HYHsin-Chih Yeh
Hsin-Chih Yeh
JSJaswinder Sharma
Jaswinder Sharma
ISIe-Ming Shih
Ie-Ming Shih
DVDung M. Vu
Dung M. Vu
JMJennifer S. Martinez
Jennifer S. Martinez
JWJames H. Werner
James H. Werner

9 December 2010 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
JSJaswinder Sharma
Jaswinder Sharma
HYHsin-Chih Yeh
Hsin-Chih Yeh
HYHyojong Yoo
Hyojong Yoo
JWJames H. Werner
James H. Werner
JMJennifer S. Martinez
Jennifer S. Martinez
We have synthesized an intrinsically fluorescent recognition ligand that combines the high fluorescence quantum yield (>50%) of oligonucleotide templated AgNCs with the specificity and strong binding affinity of DNA aptamers for their target proteins, to develop a new strategy for detection of specific proteins.

19 October 2018 in Accounts of Chemical Research
Verified
Journal Article
Closed access
YCYuxiang Chen
Yuxiang Chen
MPM. Lisa Phipps
M. Lisa Phipps
JWJames H. Werner
James H. Werner
SCSaumen Chakraborty
Saumen Chakraborty
JMJennifer S. Martinez
Jennifer S. Martinez

30 May 2012 in Nanoscale
Verified
Journal Article
Closed access
PDF file
JSJaswinder Sharma
Jaswinder Sharma
RRReginaldo C. Rocha
Reginaldo C. Rocha
MPM. Lisa Phipps
M. Lisa Phipps
HYHsin-Chih Yeh
Hsin-Chih Yeh
KBKirill A. Balatsky
Kirill A. Balatsky
JMJennifer S. Martinez
Jennifer S. Martinez
We report the discovery of a DNA sequence that templates a highly stable fluorescent silver nanocluster. In contrast to other DNA templated silver nanoclusters that have a relatively short shelf-life, the fluorescent species templated in this new DNA sequence retains significant fluorescence for at least a year. Moreover, this new silver nanocluster possesses low cellular toxicity and enhanced thermal, oxidative, and chemical stability.

1 March 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
ZSZachary R. Stromberg
Zachary R. Stromberg
MPM. Lisa Phipps
M. Lisa Phipps
HMHarsha D. Magurudeniya
Harsha D. Magurudeniya
CPChristine A. Pedersen
Christine A. Pedersen
TRTrideep Rajale
Trideep Rajale
JMJennifer S. Martinez
Jennifer S. Martinez
Biocompatible nanoparticles composed of poly(lactic-co-glycolic acid) (PLGA) are used as drug and vaccine delivery systems because of their tunability in size and sustained release of cargo molecules. While the use of toxic stabilizers such as polyvinyl alcohol (PVA) limit the utility of PLGA, stabilizer-free PLGA nanoparticles are rarely used because they can be challenging to prepare. Here, we developed a tunable, stabilizer-free PLGA nanoparticle formulation capable of encapsulating plasmid DNA and demonstrated the formation of an elastin-like polymer PLGA hybrid nanoparticle with exceptional stability and biocompatibility. A suite of PLGAs were fabricated using solvent evaporation methods and assessed for particle size and stability in water. We find that under physiological conditions (PBS at 37˚C), the most stable PLGA formulation (P4) was found to contain a greater L:G ratio (65:35), lower MW, and carboxyl terminus. Subsequent experiments determined P4 nanoparticles were as stable as those made with PVA, yet significantly less cytotoxic. Variation in particle size was achieved through altering PLGA stoichiometry while maintaining the ability to encapsulate DNA and were modified with elastin-like polymers for increased immune tolerance. Overall, a useful method for tunable, stabilizer-free PLGA nanoparticle formulation was developed for use in drug and vaccine delivery, and immune targeting.